Search Results - "Salvesen, Helga Birgitte"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    High Diagnostic Value of 18F-FDG PET/CT in Endometrial Cancer: Systematic Review and Meta-Analysis of the Literature by Bollineni, Vikram Rao, Ytre-Hauge, Sigmund, Bollineni-Balabay, Oksana, Salvesen, Helga Birgitte, Haldorsen, Ingfrid Salvesen

    Published in The Journal of nuclear medicine (1978) (01-06-2016)
    “…The aim of this study was to evaluate the diagnostic performance of (18)F-FDG PET/CT for the preoperative assessment of lymph node metastases (LNM) in…”
    Get full text
    Journal Article
  2. 2

    Growth differentiation factor-15 as biomarker in uterine sarcomas by Trovik, Jone, Salvesen, Helga Birgitte, Cuppens, Tine, Amant, Frederic, Staff, Anne Cathrine

    “…The aim of this study was to investigate and validate circulating growth differentiation factor-15 (GDF-15) as a discriminating biomarker between highly…”
    Get more information
    Journal Article
  3. 3
  4. 4

    High Diagnostic Value of super( 18)F-FDG PET/CT in Endometrial Cancer: Systematic Review and Meta-Analysis of the Literature by Bollineni, Vikram Rao, Ytre-Hauge, Sigmund, Bollineni-Balabay, Oksana, Salvesen, Helga Birgitte, Haldorsen, Ingfrid Salvesen

    Published in The Journal of nuclear medicine (1978) (01-06-2016)
    “…The aim of this study was to evaluate the diagnostic performance of super( 18)F-FDG PET/CT for the preoperative assessment of lymph node metastases (LNM) in…”
    Get full text
    Journal Article
  5. 5

    High Diagnostic Value of ^sup 18^F-FDG PET/CT in Endometrial Cancer: Systematic Review and Meta-Analysis of the Literature by Bollineni, Vikram Rao, Ytre-Hauge, Sigmund, Bollineni-Balabay, Oksana, Salvesen, Helga Birgitte, Haldorsen, Ingfrid Salvesen

    Published in The Journal of nuclear medicine (1978) (01-06-2016)
    “…The aim of this study was to evaluate the diagnostic performance of ^sup 18^F-FDG PET/CT for the preoperative assessment of lymph node metastases (LNM) in…”
    Get full text
    Journal Article
  6. 6

    Clinical value of DNA content assessment in endometrial cancer by Mauland, Karen Klepsland, Wik, Elisabeth, Salvesen, Helga Birgitte

    Published in Cytometry. Part B, Clinical cytometry (01-05-2014)
    “…Endometrial carcinoma (EC) is the most common gynecologic cancer in industrialized countries. Traditional prognostic markers include FIGO stage, histologic…”
    Get full text
    Journal Article
  7. 7

    Clinical value of dna content assessment in endometrial cancer by Mauland, Karen Klepsland, Wik, Elisabeth, Salvesen, Helga Birgitte

    Published in Cytometry. Part B, Clinical cytometry (31-01-2014)
    “…Endometrial carcinoma (EC) is the most common gynecologic cancer in industrialized countries. Traditional prognostic markers include FIGO stage, histologic…”
    Get full text
    Journal Article
  8. 8

    Switch in FOXA1 status associates with endometrial cancer progression by Tangen, Ingvild Løberg, Krakstad, Camilla, Halle, Mari K, Werner, Henrica M J, Oyan, Anne M, Kusonmano, Kanthida, Petersen, Kjell, Kalland, Karl Henning, Akslen, Lars A, Trovik, Jone, Hurtado, Antoni, Salvesen, Helga B

    Published in PloS one (21-05-2014)
    “…The transcription factor Forkhead box A1 (FOXA1) is suggested to be important in hormone dependent cancers, although with little data for endometrial cancer…”
    Get full text
    Journal Article
  9. 9
  10. 10

    MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk by Knappskog, Stian, Gansmo, Liv B, Romundstad, Pål, Bjørnslett, Merete, Trovik, Jone, Sommerfelt-Pettersen, Jan, Løkkevik, Erik, Tollenaar, Rob A E M, Seynaeve, Caroline, Devilee, Peter, Salvesen, Helga B, Dørum, Anne, Hveem, Kristian, Vatten, Lars, Lønning, Per E

    Published in PloS one (30-04-2012)
    “…The MDM2 proto-oncogene plays a key role in central cellular processes like growth control and apoptosis, and the gene locus is frequently amplified in…”
    Get full text
    Journal Article